| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |